Here are five takeaways:
1. An increasing number of neurological disorders and more advanced technology spur the market’s growth in North America.
2. Asia is anticipated to significantly grow in the market because of research, development activities and more government support.
3. India, China and Japan will lead the growth in the Asia market.
4. Expensive equipment, regulatory requirement and poor reimbursement will hinder the market’s growth.
5. Some key companies include Codman & Shurtleff, Medtronic, B. Braun Melsungen, Stryker, BrainLab, Integra LifeSciences and St. Jude Medical.
More articles on spine:
Neurosurgeon Dr. Madhavan Pisharodi receives solar panel patent — 5 highlights
New mouse model to help ALS research — 5 highlights
How reliable is a new MRI scoring system for inflammatory facet joints in ankylosing spondylitis? 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.